Corpus Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.65 Cr
- Revenue Growth 16.34%
- Profit Growth 268.74%
- Ebitda -90.30%
- Net Worth 28.02%
- Total Assets 19.29%
About Corpus Lifescience
Corpus Lifescience Private Limited (CLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 December 2012 and has a history of 12 years and one month. Its registered office is in Hooghly, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹11.65 Cr.
Debasish Das and Krishnendu Baksi serve as directors at the Company.
Company Details
-
Location
Hooghly, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909WB2012PTC189172
-
Company No.
189172
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Dec 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Corpus Lifescience Private Limited offer?
Corpus Lifescience Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Anti Infective Drugs & Medicines, Anti Allergic Drug.
Who are the key members and board of directors at Corpus Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnendu Baksi
|
Director | 13-Dec-2012 | Current |
|
Debasish Das
|
Director | 13-Dec-2012 | Current |
Financial Performance of Corpus Lifescience.
Corpus Lifescience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.34% increase. The company also saw a substantial improvement in profitability, with a 268.74% increase in profit. The company's net worth Soared by an impressive increase of 28.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corpus Lifescience?
Unlock access to Corpus Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹116.52 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.96 Cr
- Axis Bank Limited : 4.16 Cr
- Hdfc Bank Limited : 0.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2022 | Others | ₹2.92 Cr | Open |
| 24 May 2022 | Others | ₹3.56 M | Open |
| 24 Dec 2020 | Hdfc Bank Limited | ₹0.30 M | Open |
| 13 Jul 2020 | Axis Bank Limited | ₹4.80 M | Open |
| 29 Nov 2019 | Axis Bank Limited | ₹2.10 M | Open |
How Many Employees Work at Corpus Lifescience?
Corpus Lifescience has a workforce of 74 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corpus Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corpus Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.